SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-045431
Filing Date
2019-12-06
Accepted
2019-12-06 10:47:43
Documents
13
Period of Report
2019-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - ANNUAL MEETING mygn-8k_20191205.htm   iXBRL 8-K 103429
2 EX-10.1 mygn-ex101_15.htm EX-10.1 106661
  Complete submission text file 0001564590-19-045431.txt   359398

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mygn-20191205.xsd EX-101.SCH 5960
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20191205_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20191205_pre.xml EX-101.PRE 11167
11 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8k_20191205_htm.xml XML 3412
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 191272070
SIC: 2835 In Vitro & In Vivo Diagnostic Substances